Biopharmaceuticals Manufacturing
Aspiring to be at the forefront of research or a scientist who discovers the cure to diseases? With its fast pace of growth, Singapore unveiled its vision to transform itself into a regional biomedical hub.
Singapore's vibrant biopharmaceutical manufacturing industry offers boundless opportunities for growth and innovation, where breakthroughs in science and medicine come to life, shaping a brighter, healthier future for all.
Key Industry Facts
There are over 9,000 professionals working in biopharmaceutical manufacturing.
Singapore’s biopharmaceutical sector exported pharmaceuticals and biologics worth SGD 21 billion.
This industry accounts for over SGD 30 billion in manufacturing output in 2020.
Industry Trends
Cutting-Edge Biomanufacturing
Singapore is adopting innovative Biomanufacturing technologies, including continuous processing and single-use systems, to boost production efficiency and product quality in the Biopharmaceutical sector.
Digitalisation and Data Analysis
Singapore's biopharmaceutical manufacturing sector is embracing digitalisation, harnessing data analytics, artificial intelligence, and machine learning to streamline processes, monitor real-time production, and ensure compliance with regulatory standards.
Biologics and Biosimilars Boom
There is a surge and demand in the development and production of biologics (eg. vaccines and growth factors)and biosimilars (alternative medicines), aligning with the global demand for complex therapies and cost-effective alternatives to Biopharmaceuticals.
You have bookmarked your first item!
Find it in My Discoveries with insights on your interests!